Women's Health

What Causes Brittle Nails in PCOS?

Brittle, peeling, or slow-growing nails are one of the quieter complaints in PCOS — but they're rarely random. Androgen excess, insulin resistance, and the nutrient depletions that follow hormonal shifts all chip away at nail plate integrity. Understanding which driver is dominant in your case is where targeted support begins.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·8 min read
PCOSbrittle nailswomen's healthnail healthhormonal healthperimenopause
What Causes Brittle Nails in PCOS?

What Causes Brittle Nails in PCOS?

Yes, PCOS directly causes brittle nails — through at least three overlapping mechanisms: androgen-driven disruption of the nail matrix, insulin resistance that starves follicles of glucose, and micronutrient depletion (especially zinc, biotin, and iron) that is common in the condition. The exception is women whose PCOS is lean-phenotype with normal androgens, where nutrient deficiency is usually the dominant driver rather than hormonal imbalance.

---

How PCOS Disrupts Nail Structure at the Root

The nail plate grows from the nail matrix, a specialized tissue that requires a steady supply of keratin-building amino acids, cofactor minerals, and adequate blood glucose. PCOS interferes with all three pathways simultaneously.

Androgen excess and the nail matrix. Elevated free testosterone and dihydrotestosterone (DHT) — hallmarks of PCOS — alter keratinocyte proliferation in the matrix. The same androgens that miniaturize scalp follicles and drive hirsutism can paradoxically reduce nail plate density, producing thin, brittle nails that peel in layers. Research confirms that androgen receptor expression is present in nail matrix cells, making them a target tissue for hormonal fluctuation (Randall 2008; PMID: 18498551).

Insulin resistance and poor nutrient delivery. Up to 70–80% of women with PCOS have some degree of insulin resistance, even at normal body weight (Stepto et al., Journal of Clinical Endocrinology & Metabolism 2013; PMID: 23150689). Chronically elevated insulin triggers compensatory hyperinsulinemia that worsens androgen output from the ovaries (the theca cells upregulate androgen synthesis in high-insulin environments). It also impairs peripheral microcirculation — the tiny capillaries that supply the nail bed are among the first to show reduced perfusion in metabolic dysfunction, reducing the delivery of zinc, biotin, and amino acids directly to the matrix.

Zinc depletion — a specific PCOS pattern. Multiple cross-sectional studies have found serum zinc is significantly lower in women with PCOS compared to age-matched controls. A 2013 study (Kanafchian et al., Iranian Journal of Reproductive Medicine; PMID: 24639780) found zinc levels inversely correlated with androgen markers in PCOS. Zinc is critical for keratin cross-linking — the process that gives the nail plate its hardness. Without adequate zinc, the plate grows with structural gaps that predispose to cracking and splitting.

Biotin and the keratin synthesis pathway. Biotin (vitamin B7) acts as a coenzyme for carboxylase enzymes involved in fatty acid synthesis and amino acid metabolism — both essential for building the keratin scaffold of the nail. A double-blind trial of 2.5 mg biotin daily over six months showed a 25% increase in nail plate thickness in patients with brittle nails (Hochman et al., Journal of the American Academy of Dermatology 1993; PMID: 8444131). Women with PCOS who also have gut dysbiosis or take metformin (which depletes B12 and may reduce B-vitamin absorption over time) are at compounded risk.

For a deeper look at how hormonal and metabolic signals show up on standard lab panels, the guide on what causes high fasting insulin walks through how to interpret these results in a hormonal context.

---

What Causes Brittle Nails When Coming Off the Pill?

Many women with PCOS are prescribed oral contraceptives to manage androgen excess. When they discontinue — often to conceive or because of side effects — nail changes are a common but underrecognized withdrawal effect.

The mechanism is a post-pill androgen rebound. Synthetic estrogens in combined OCP raise sex hormone–binding globulin (SHBG), which mops up free testosterone. When the pill stops, SHBG falls sharply over 3–6 months, unmasking pre-existing androgen excess that was chemically suppressed. This rebound often exceeds pre-pill androgen levels temporarily.

Simultaneously, oral contraceptives deplete several micronutrients with direct relevance to nail health: zinc (excreted at higher rates in OCP users), B6, B12, folate, and magnesium. The combined depletion plus androgen surge creates a nail quality crisis that typically peaks 2–4 months after stopping. Women in this transition period often benefit from targeted repletion before the body re-equilibrates — something a personalized formula calibrated to current lab values can address precisely.

---

What Causes Brittle Nails in Perimenopause?

Perimenopause — the 4–10 year transition before the final menstrual period — introduces erratic estrogen fluctuation on top of whatever baseline hormonal pattern a woman already carried. For women with PCOS who enter perimenopause, this is often a compounding rather than a resolving event.

Estrogen plays a direct structural role in nail health. Estrogen receptors are expressed in the nail matrix and surrounding connective tissue. As estrogen begins to fluctuate and trend downward in perimenopause, collagen synthesis in the nail bed declines, the nail plate loses water-binding capacity, and longitudinal ridging — a visible sign of matrix aging — accelerates.

Iron deficiency is also particularly prevalent during perimenopause due to heavier or irregular cycles. Koilonychia (spoon-shaped nails) and brittleness are classic signs of iron-deficiency anemia, but suboptimal ferritin — even with hemoglobin still in range — is sufficient to impair matrix function. A ferritin level below 40 ng/mL is associated with impaired keratin synthesis in multiple observational studies.

For women tracking their cardiovascular risk markers alongside hormonal changes, understanding what causes HDL to be out of range and what causes triglycerides to be out of range can provide a fuller metabolic picture during this transition, since cardiometabolic risk escalates in the late perimenopause window.

---

What Causes Brittle Nails in Menopause and Postmenopause?

At the menopausal transition and in the years following, estrogen production from the ovaries effectively ceases. This is when nail changes that were intermittent in perimenopause become persistent and progressive if not addressed.

Collagen loss is the primary structural driver. Skin and connective tissue lose approximately 30% of their collagen in the first five years after menopause (Brincat et al., Maturitas 2005; PMID: 15748625). The nail plate is itself a keratin-collagen composite structure supported by the connective tissue of the nail bed. As collagen scaffolding thins, the plate becomes prone to onychorrhexis (longitudinal splitting) and onychoschizia (lamellar peeling at the free edge).

Silicon (silica) and collagen cross-linking. Orthosilicic acid — the bioavailable form of silicon — is a required cofactor for the hydroxylation of proline and lysine in collagen synthesis. Studies in postmenopausal women show that supplemental silicon improves skin collagen density and nail brittleness scores (Barel et al., Archives of Dermatological Research 2005; PMID: 15864816). This mechanism is particularly relevant in postmenopause when baseline collagen turnover is already compromised.

Thyroid function in postmenopause. Hypothyroidism rates rise steeply in postmenopause and produce their own signature nail changes: slow growth, brittleness, and thickening. Because many thyroid symptoms overlap with estrogen-deficiency symptoms, subclinical hypothyroidism is frequently missed in this population. A full thyroid panel — TSH, free T3, free T4, and TPO antibodies — should be part of any workup for post-menopausal nail changes.

For a broader picture of how brittle nails intersect with silica, biotin, and keratin nutrition, the article on weak nails and brittle hair: silica, biotin, and keratin nutrition provides a useful complement to this hormonal framing.

---

The Nutrient and Hormonal Biomarkers Worth Checking

If you are experiencing brittle nails in any of these hormonal contexts, these are the most actionable labs to request:

BiomarkerOptimal Range (Functional)What It Tells You
Serum zinc80–120 mcg/dLDirect nail plate quality signal
Ferritin≥ 40 ng/mLKeratin synthesis threshold
Free testosteroneLower quartile of referenceAndrogen burden on matrix
DHEA-SAge-appropriate mid-rangeAdrenal androgen contribution
SHBGNot suppressed (> 30 nmol/L)Bioavailable androgen index
TSH + free T4TSH 1.0–2.5 mIU/LThyroid-nail connection
Biotin (urine 3-HIA)Above thresholdB-vitamin status
25-OH Vitamin D40–60 ng/mLImmune and keratinocyte function

Insulin resistance sits beneath many of these findings. If your fasting glucose is trending up alongside nail changes, the guide on what causes high fasting glucose explains how to read that number in context.

---

What This Means for Your Formula

Ones builds custom capsule formulas using a curated catalog of clinically dosed ingredients — and the hormonal and metabolic drivers of brittle nails in PCOS map directly onto several of them.

Zinc (individual active). Ones includes zinc at doses calibrated to serum zinc levels identified in your blood work. Zinc supplementation in women with PCOS has been shown to lower free androgen index and improve oxidative stress markers, with dose ranges typically studied between 30–50 mg elemental zinc (Foroozanfard et al., Hormone and Metabolic Research 2015; PMID: 25506742). Because zinc and copper compete for absorption, the formula is calibrated carefully to avoid overcorrection — a nuance that matters when building a precision stack.

Silica (via the Ligament Support blend). Ones' Ligament Support blend incorporates bioavailable silicon to support collagen cross-linking — directly relevant for postmenopausal and peri-menopausal nail fragility driven by connective tissue changes rather than androgen excess alone.

Vitamin D3 + K2 (MK-7). Vitamin D receptors are expressed in keratinocytes and play a regulatory role in nail matrix differentiation. Ones includes D3 co-formulated with MK-7 (vitamin K2), which ensures calcium is directed to connective tissue rather than soft tissue — an important distinction for women in the peri- and postmenopausal window who are managing both bone density and nail integrity simultaneously.

The formula plan — whether 6 or 9 capsules daily — is selected by the Ones AI based on the full picture of your lab results, wearable data, and health history. The depth of the panel determines where the formula focuses.

---

Key Takeaways

  • PCOS causes brittle nails through three overlapping mechanisms: androgen excess disrupting the nail matrix, insulin resistance impairing nutrient delivery, and micronutrient depletion (especially zinc and biotin).
  • Coming off the pill triggers an androgen rebound plus nutrient depletion that typically peaks 2–4 months post-cessation — a transition window where targeted repletion is most valuable.
  • Perimenopause compounds PCOS-related nail fragility through estrogen fluctuation, declining collagen synthesis, and rising rates of iron deficiency from irregular cycles.
  • Postmenopause nail brittleness is primarily collagen-driven, with silica (orthosilicic acid) and connective tissue support being the most evidence-backed interventions alongside thyroid screening.
  • Key labs to check include ferritin, serum zinc, free testosterone, SHBG, TSH, and 25-OH Vitamin D — these differentiate the dominant driver and direct the intervention.
  • Personalized formulas calibrated to your specific lab values outperform generic nail supplements, because the same symptom (brittle nails) can stem from androgen excess, iron deficiency, thyroid dysfunction, or collagen loss — each requiring a different approach.

Always consult a qualified healthcare provider before making changes to your supplement regimen, particularly if you are managing a diagnosed hormonal condition like PCOS.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading